Work

RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma

Year: 2022

Type: article

Source: British Journal of Cancer

DOI: 10.1038/s41416-022-01810-w

Authors: Christine Hjorth Andreassen, Mette Lorenzen, John E. Nielsen, Sam Kafai Yahyavi, Birgitte Grønkær Toft, Lars R. Ingerslev, Christoffer Clemmensen, Lene Juel Rasmussen, Carsten Bokemeyer, Anders Juul, Anne Jørgensen, Martin Blomberg Jensen

Institutions: Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Novo Nordisk Foundation Center for Basic Metabolic Research, University Medical Center Hamburg-Eppendorf, Harvard University

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Novo Nordisk, Novo Nordisk Fonden, Novo Nordisk Foundation Center for Basic Metabolic Research, Centro de Investigação em Biomedicina

Awards: G1819251723, G2010485691, G2755835583, G6574565787, G6788588247, G8407745595

OpenAlex ID: W4224024017

FWCI: 1.434

Cites: 81

Cited by: 8

Related to: 10